Published in Cancer Weekly, February 3rd, 2004
Concurrently, Given Imaging announced that Blue Cross and Blue Shield of Alabama has approved reimbursement coverage for capsule endoscopy in the initial diagnosis in patients with suspected Crohn disease following negative conventional diagnostic tests such as endoscopy of the upper or lower gastrointestinal tract.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.